Figure 1.
Kaplan-Meier curves showing effect of recurrent 1B group status on late post-transplant outcomes. (a) Freedom from late (>1 year) grade ≥3A/2R acute cellular rejection. (b) Freedom from post-transplant coronary artery disease. (c) Freedom from re-transplantation/death. (d) Freedom from composite end-point (late ≥3A/2R ACR, coronary artery disease, or re-transplantation/death).